Amalgamated Bank Heron Therapeutics, Inc. Transaction History

Amalgamated Bank

$11.7 Billion
Q1 2025

A detailed history of Amalgamated Bank transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 4,047 shares of HRTX stock, worth $8,417. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,047

Previous 3,604 12.29%

Holding current value

$8,417

Previous $6,000 50.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$1.47 - $2.55 $651 - $1,129	443 Added 12.29%	4,047 $9,000
Q1 2024 Apr 23, 2024	SELL	$1.71 - $3.06 $18,538 - $33,173	-10,841 Reduced 75.05%	3,604 $10,000
Q4 2023 Feb 06, 2024	SELL	$0.54 - $1.82 $579 - $1,952	-1,073 Reduced 6.91%	14,445 $25,000
Q2 2023 Aug 11, 2023	BUY	$1.11 - $2.88 $1,239 - $3,216	1,117 Added 7.76%	15,518 $18,000
Q1 2023 May 02, 2023	SELL	$1.51 - $3.25 $3,261 - $7,020	-2,160 Reduced 13.04%	14,401 $22,000
Q3 2022 Nov 09, 2022	BUY	$2.66 - $5.37 $707 - $1,428	266 Added 1.63%	16,561 $70,000
Q2 2022 Aug 15, 2022	BUY	$2.3 - $6.29 $2,879 - $7,875	1,252 Added 8.32%	16,295 $45,000
Q1 2022 Jun 30, 2022	SELL	$4.63 - $9.94 $5,870 - $12,603	-1,268 Reduced 7.77%	15,043 $86,000
Q4 2021 Feb 15, 2022	SELL	$8.35 - $12.6 $1,477 - $2,230	-177 Reduced 1.07%	16,311 $149,000
Q3 2021 Oct 29, 2021	SELL	$10.13 - $15.0 $9,714 - $14,385	-959 Reduced 5.5%	16,488 $176,000
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $66,137 - $92,104	4,984 Added 39.99%	17,447 $271,000
Q1 2021 May 13, 2021	SELL	$14.49 - $20.72 $17,967 - $25,692	-1,240 Reduced 9.05%	12,463 $202,000
Q4 2020 Feb 12, 2021	BUY	$14.61 - $22.14 $1,124 - $1,704	77 Added 0.57%	13,703 $290,000
Q3 2020 Oct 30, 2020	SELL	$13.67 - $17.77 $5,509 - $7,161	-403 Reduced 2.87%	13,626 $202,000
Q2 2020 Aug 10, 2020	SELL	$10.89 - $21.47 $11,804 - $23,273	-1,084 Reduced 7.17%	14,029 $206,000
Q1 2020 May 13, 2020	SELL	$10.23 - $24.56 $5,473 - $13,139	-535 Reduced 3.42%	15,113 $177,000
Q4 2019 Feb 13, 2020	BUY	$17.42 - $26.61 $45,832 - $70,010	2,631 Added 20.21%	15,648 $368,000
Q3 2019 Nov 13, 2019	SELL	$16.36 - $21.39 $3,222 - $4,213	-197 Reduced 1.49%	13,017 $241,000
Q2 2019 Aug 14, 2019	BUY	$16.93 - $26.22 $45,152 - $69,928	2,667 Added 25.29%	13,214 $246,000
Q1 2019 May 15, 2019	BUY	$23.15 - $28.34 $9,699 - $11,874	419 Added 4.14%	10,547 $258,000
Q4 2018 Feb 15, 2019	BUY	$22.03 - $32.01 $223,119 - $324,197	10,128 New	10,128 $263,000
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $292,350 - $398,083	-9,745 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$26.4 - $42.0 $257,268 - $409,290	9,745 New	9,745 $379,000

Others Institutions Holding HRTX

# of Institutions

182

Shares Held

125M

Call Options Held

847K

Put Options Held

47.7K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $247M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Heron Therapeutics, Inc. Transaction History